La cadena de opciones muestra datos clave de las opciones de acciones de Fortrea Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Fortrea Holdings..

Fortrea Holdings (NASDAQ:FTRE) Bolsa, Cadena de Opciones

FORTREA HOLDINGS INC

Fortrea Holdings

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

News

Pre-Market Outlook

Markets

Trading Ideas

BEKE

FTRE

MNDY

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: MNDY, SLF, BRT, FTRE y BEKE.

5 acciones en el foco este lunes: MNDY, SLF, BRT, FTRE y BEKE

Fortrea Holdings Inc

Jefferies analyst Brent Thill maintains Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) with a Buy and lowers the price target from $150 to $135.

Price Target

Analyst Ratings

DDOG

Jefferies Maintains Buy on Datadog, Lowers Price Target to $135

US Markets­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/25/04/44662164/us-stock-futures-slump-following-massive-tariff-induced-selloff-experts-warn-of-a-brewing-great-depression-like-pattern">US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing &#8216;Great Depression-Like&#8217; Pattern</a></li>
<li><a href="https://www.benzinga.com/25/04/44661746/dow-dips-over-2200-points-investor-sentiment-dips-further-fear-greed-index-remains-in-extreme-fear-zone">Dow Nosedives Over 2,200 Points As Apple, Tesla, Nvidia Plummet: Investor Sentiment Dips Further, Greed Index Remains In &#8216;Extreme Fear&#8217; Zone</a></li>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44660779/sp-500-dow-jones-on-course-to-mimic-rare-consecutive-losses-not-seen-since-the-great-depression-whats-driving-the-fear">S&amp;P 500, Dow Jones On Course To Mimic Rare Consecutive Losses Not Seen Since The Great Depression: What&#8217;s Driving the Fear?</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44660089/japans-nikkei-futures-halted-hang-seng-crashes-8-8-as-global-market-rout-accelerates-on-tariff-shock-analyst-says-trumps-iphone-only-real-circuit-breaker">Japan&#8217;s Nikkei Futures Halted, Hang Seng Crashes 8.8% As Global Market Rout Accelerates On Tariff Shock — Analyst Says Trump&#8217;s iPhone &#8216;Only Real Circuit Breaker</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44659686/stock-futures-tank-dow-sheds-over-1000-points-as-white-house-remains-firm-on-tariffs-trump-says-sometimes-you-have-to-take-medicine">Stock Futures Tank, Dow Sheds Over 1000 Points As White House Remains Firm On Tariffs: Trump Says, &#8216;Sometimes You Have To Take Medicine&#8217;</a></li>
</ul>
Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44664914/bitcoin-ethereum-xrp-dogecoin-obliterate-142-billion-in-liquidations-plummet-up-to-16">Bitcoin, Ethereum, XRP, Dogecoin Obliterate $1.42 Billion In Liquidations, Plummet Up To 16%</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44662677/trumps-tariff-moves-have-hammered-crypto-market-but-this-large-cap-coin-holds-steady">Trump&#8217;s Second Term Hasn&#8217;t Been Favorable To The Crypto Market, But This Large-Cap Coin Holds Steady</a></li>
<li><a href="https://www.benzinga.com/25/04/44661347/xrp-futures-traders-bet-on-cryptos-price-increase-despite-a-20-fallheres-what-analysts-predict">XRP Futures Traders Bullish On Coin&#8217;s Price Increase Despite A 20% Fall — Analyst Terms Decline As &#8216;Small Speed Bump&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44661331/bitcoin-could-test-70k-amid-fears-of-black-monday-panic-says-analyst-van-de-poppe-as-global-markets-slide-on-trump-tariff-shock">Bitcoin Could Test $70K Amid Fears Of &#8216;Black Monday&#8217; Panic, Says Analyst Van de Poppe, As Global Markets Slide On Trump Tariff Shock</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/44660568/fartcoin-returns-over-8-in-a-week-marked-by-dogecoin-ethereum-bloodbath">Fartcoin Returns Over 8% In A Week Marked By Dogecoin, Ethereum Bloodbath</a></li>
<li><a href="https://www.benzinga.com/25/04/44660141/odds-of-recession-federal-reserves-emergency-rate-cuts-soar-on-crypto-based-polymarket-as-tariff-fears-pummel-markets">Odds Of 2025 Recession Soar Above 60% On Crypto-Based Polymarket As Tariff Fears Pummel Markets, Bettors Root For Emergency Rate Cut</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/44659799/bitcoin-plunges-below-80000-ethereum-dogecoin-crash-as-cryptocurrencies-mirror-stocks-amid-trump-tariff-mayhem-analyst-flags-critical-support-level-for-btc">Bitcoin Plunges Below $80,000, Ethereum, Dogecoin Crash As Cryptocurrencies Mirror Stocks Amid Trump Tariff Mayhem: Analyst Flags &#8216;Critical Support Level&#8217; For BTC</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/25/04/44663112/us-families-to-see-3800-annual-price-hike-says-experts-even-as-trump-indicates-tariff-windfall-of-tens-of-billions-of-dollars">Trump Tariffs Could Cost American Families $3,800 More Per Year — But President Says They&#8217;re &#8216;Bringing Tens Of Billions Of Dollars Into The US&#8217;</a></li>
<li><a href="https://www.benzinga.com/personal-finance/25/04/44661713/a-beautiful-word-why-trump-insists-on-tariffs-as-essential-in-his-bid-to-save-american-manufacturing">A Beautiful Word&#8217;: Why Trump Insists On Tariffs As Essential In His Bid To Save American Manufacturing</a></li>
<li><a href="https://www.benzinga.com/markets/25/04/44661387/trump-advisor-navarro-hits-back-at-elon-musks-tariff-criticism-just-looking-out-for-his-own-interests">Trump Advisor Navarro Hits Back At Elon Musk&#8217;s Tariff Criticism: &#8216;Just Looking Out For His Own Interests&#8217;</a></li>
<li><a href="https://www.benzinga.com/25/04/44660475/more-than-50-nations-ready-to-revisit-tariffs-says-white-house-advisor">Trump White House Says Over 50 Nations Ready To Come To The Table On Tariffs</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/25/04/44661530/singapores-leaders-express-concern-over-us-tariffs-markets-take-a-hit">Trump Tariff Will &#8216;Spell Trouble For All Nations,&#8217; Says Singapore&#8217;s PM — Despite Country Facing One Of The Lowest Tariffs In Southeast Asia</a></li>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44660696/trumps-tariff-worries-ross-gerber-points-out-ordering-eu-goods-under-800-still-keeps-you-tax-free">Trump&#8217;s Tariff Worries? Ross Gerber Points Out Ordering EU Goods Under $800 Still Keeps You Tax-Free</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/25/04/44665493/us-recession-countdown-has-begun-as-trump-tariffs-push-odds-to-45-goldman-sachs-warns">US Recession &#8216;Countdown&#8217; Has Begun As Trump Tariffs Push Odds To 45%, Goldman Sachs Warns</a></li>
<li><a href="https://www.benzinga.com/25/04/44665530/jamie-dimon-once-a-tariff-supporter-warns-trumps-new-policy-could-slow-us-growth-fuel-inflation-the-quicker-the-issue-is-resolved-the-better">Jamie Dimon, Once A Tariff Supporter, Warns Trump&#8217;s New Policy Could Stall US Growth, Stoke Inflation: &#8216;The Quicker The Issue Is Resolved, The Better&#8217;</a></li>
<li><a href="https://www.benzinga.com/25/04/44662991/goldman-sachs-raises-risk-of-recession-to-45-jefferies-calls-tariffs-a-free-hall-pass-for-tech-giants-to-reset-their-goals">Goldman Sachs Raises Risk Of Recession to 45%: Jefferies Calls Tariffs a &#8216;Free Hall Pass&#8217; For Tech Giants To Reset Their Goals</a></li>
<li><a href="https://www.benzinga.com/25/04/44662249/end-of-cheap-clothing-era-tariffs-to-hit-apparel-industry-hard">Tariffs Threaten To End Era Of Cheap Clothing — Apparel Industry Faces Major Price Shock Under Trump Policy</a></li>
<li><a href="https://www.benzinga.com/25/04/44661665/manufacturing-resurgence-not-without-a-workforce-says-blackrocks-fink">BlackRock CEO Larry Fink Warns US Manufacturing Revival Faces Labor, Immigration Hurdles</a></li>
<li><a href="https://www.benzinga.com/25/04/44661029/trump-and-fed-stand-firm-lack-of-a-put-could-drive-the-market-lower-very-quickly-warns-expert">Lack Of &#8216;Trump Put&#8217; Could Drive Market Lower &#8216;Very Quickly,&#8217; Says Expert, As Fed Chair Jerome Powell Stands Ground On Rate Cuts</a></li>
</ul>
World Economy
<ul>
<li><a href="https://www.benzinga.com/25/04/44663034/asia-in-freefall-hang-seng-posts-worst-drop-since-1997-europe-market-tumbles-oil-slips-gold-eases-global-markets-today-while-us-slept">Global Markets See Worst Drop Since 1997 Mimicking Black Monday Like Crash, Crude Oil Tumbles</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44665047/broadcom-analog-devices-could-slide-10-analyst-warns-but-a-bottom-could-be-near">Broadcom, Analog Devices Could Slide ~10%, Analyst Warns, But A Bottom Could Be Near</a></li>
<li><a href="https://www.benzinga.com/25/04/44665331/gilat-wins-defense-support-deal-worth-up-to-23-million-for-global-satcom-services">Gilat Wins Defense Support Deal Worth Up To $23 Million For Global SATCOM Services</a></li>
<li><a href="https://www.benzinga.com/25/04/44665533/taiwan-semiconductor-stock-tumbles-as-tariff-fears-spark-global-tech-selloff">Taiwan Semiconductor Stock Tumbles As Tariff Fears Spark Global Tech Selloff</a></li>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44663682/tesla-nvidia-apple-and-other-magnificent-7-peers-tank-in-monday-premarket-whats-going-on">Tesla, Nvidia, Apple And Other &#8216;Magnificent 7&#8217; Peers Tank In Monday Premarket: What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/25/04/44663080/apple-facebook-and-google-become-bargaining-chips-in-us-trade-war-eu-threatens-retaliation-uk-offers-tax-relief-for-lower-tariffs">Apple, Facebook, And Google Become Bargaining Chips In US Trade War: EU Threatens Retaliation, UK Offers Tax Relief For Lower Tariffs</a></li>
<li><a href="https://www.benzinga.com/25/04/44662708/top-analyst-ming-chi-kuo-warns-semiconductor-stocks-face-near-term-risks-under-trump-tariff-policy-even-apples-500-billion-us-investment-didnt-buy-it-leniency">Ming-Chi Kuo Warns Semiconductor Stocks Face Near-Term Risks Under Trump Tariff Policy: Even Apple&#8217;s $500 Billion US Investment Didn&#8217;t Buy It Leniency</a></li>
<li><a href="https://www.benzinga.com/25/04/44661965/trumps-reciprocal-tariff-threat-wipes-out-nearly-18-trillion-from-magnificent-7-dan-ives-warns-it-could-set-us-tech-back-a-decade-investors-know-math-and-the-sad-reality">Trump&#8217;s &#8216;Reciprocal&#8217; Tariff Threat Wipes Out Nearly $1.8 Trillion From Magnificent 7, Dan Ives Warns It Could Set US Tech Back A Decade: &#8216;Investors Know Math And The Sad Reality&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/25/04/44661561/mark-zuckerbergs-meta-unveils-latest-llama-4-ai-models-to-challenge-openais-chatgpt-4-and-googles-gemini">Mark Zuckerberg&#8217;s Meta Unveils Latest Llama 4 AI Models To Challenge OpenAI&#8217;s ChatGPT 4 And Google&#8217;s Gemini</a></li>
<li><a href="https://www.benzinga.com/markets/25/04/44660218/howard-lutnick-says-army-of-millions-will-build-iphones-in-the-us-but-could-trumps-tariffs-make-the-premium-apple-flagship-cost-2300">Howard Lutnick Says Army Of Millions Will Build iPhones In The US, But Could Trump&#8217;s Tariffs Make The Premium Apple Flagship Cost $2,300?</a></li>
<li><a href="https://www.benzinga.com/25/04/44665484/warren-buffetts-berkshire-hathaway-outpaces-sp-500-adds-8781-billion-in-investor-wealth-in-2025">Warren Buffett&#8217;s Berkshire Hathaway Unfazed By Trump Tariff-Triggered Market Selloff: Shares Up 9.41% YTD, Adding $87.81 Billion In Investor Wealth In 2025</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/news/offerings/25/04/44666201/nio-stock-is-moving-lower-monday-whats-going-on">Nio Stock Is Moving Lower Monday: What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/25/04/44662021/is-tesla-cybertruck-the-biggest-automotive-blunder-in-decades-after-fords-edsel-its-a-huge-swing-and-a-huge-miss">Is Tesla Cybertruck The Biggest Automotive Blunder In Decades After Ford&#8217;s Edsel? &#8216;It&#8217;s A Huge Swing And A Huge Miss,&#8217; Says Expert</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44659926/dan-ives-cuts-tesla-target-to-315-slashes-apple-by-23-amid-tariff-fallout-warns-elon-musk-led-ev-maker-faces-darker-days-ahead">Dan Ives Cuts Tesla Target To $315, Slashes Apple By 23% Amid Tariff Fallout, Warns Elon Musk-Led EV Maker Faces &#8216;Darker Days&#8217; Ahead</a></li>
</ul>
Consumer
<ul>
<li><a href="https://www.benzinga.com/25/04/44663006/rpm-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">RPM Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Communication
<ul>
<li><a href="https://www.benzinga.com/25/04/44662003/netflix-seen-as-safe-bet-amid-market-volatility-says-analyststrong-value-digital-model-make-it-recession-ready">Netflix Seen As Safe Bet Amid Market Volatility, Says Analyst: Strong Value, Digital Model Make It Recession-Ready</a></li>
<li><a href="https://www.benzinga.com/25/04/44661399/eu-reportedly-set-to-fine-elon-musks-x-over-1-billion-for-violating-new-digital-act-x-labels-it-an-unprecedented-act-of-political-censorship">EU Reportedly Set To Fine Elon Musk&#8217;s Social Media Platform Over $1 Billion For Violating New Digital Act: X Calls It &#8216;An Unprecedented Act Of Political Censorship&#8217;</a></li>
</ul>
Industrial
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44665424/regional-airline-shakeup-republic-mesa-to-merge-in-all-stock-deal-stock-soars">Regional Airline Shakeup: Republic, Mesa To Merge In All-Stock Deal; Stock Soars</a></li>
<li><a href="https://www.benzinga.com/25/04/44663650/top-3-defensive-stocks-that-are-preparing-to-pump-this-month-2">Top 3 Defensive Stocks That Are Preparing To Pump This Month</a></li>
</ul>
Financial
<ul>
<li><a href="https://www.benzinga.com/markets/bonds/25/04/44660747/bond-king-jeff-gundlach-says-fed-rate-is-too-high-by-75-bps-but-warns-cuts-unlikely-without-sharper-risk-asset-losses">&#8216;Bond King&#8217; Jeff Gundlach Says Fed Rate Is &#8216;Too High&#8217; By 75 Bps, But Warns Cuts Unlikely Without Sharper Risk Asset Losses</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44660250/peter-schiff-warns-against-taking-investment-advice-from-trumps-as-eth-crashes-45-since-eric-trumps-push">Peter Schiff Warns Against Taking Investment Advice From Trumps As ETH Crashes 45% Since Eric Trump&#8217;s Push</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/44663047/i-do-better-in-bad-markets-trumps-2012-comments-gain-steam-as-tariff-medicine-wrecks-global-stocks-and-sparks-fears-of-deliberate-economic-fallout">&#8216;I Do Better In Bad Markets&#8217;: Trump&#8217;s 2012 Comments Gain Steam As Tariff &#8216;Medicine&#8217; Wrecks Global Stocks And Sparks Fears Of Deliberate Economic Fallout</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44661978/bill-ackman-blames-market-collapse-on-tariff-timing-says-trump-advisor-should-be-fired-now-predicts-a-lot-more-than-5-dip">Bill Ackman Blames Market Collapse On Tariff Timing, Says Trump Advisor &#8216;Should Be Fired Now:&#8217; Predicts &#8216;A Lot More Than 5%&#8217; Dip</a></li>
<li><a href="https://www.benzinga.com/markets/equities/25/04/44660335/chamath-palihapitiya-warns-fed-and-trump-may-no-longer-rescue-markets-as-bottom-50-of-americans-have-zero-interest-in-stocks">Chamath Palihapitiya Warns Fed And Trump May No Longer Rescue Markets As Bottom 50% Of Americans Have &#8216;Zero Interest&#8217; In Stocks</a></li>
<li><a href="https://www.benzinga.com/news/25/04/44659521/bill-ackman-warns-against-launching-economic-nuclear-war-wants-a-90-day-time-out-on-trump-tariffs">Bill Ackman Warns Against Launching &#8216;Economic Nuclear War,&#8217; Wants A 90-Day Time Out On Trump Tariffs</a></li>
</ul>
Energy
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/04/44665396/shell-updates-q1-outlook-tightens-production-ranges-flags-write-offs-and-maintenance">Shell Lowers Q1 Production Outlook, Flags Write-Offs And Maintenance</a></li>
<li><a href="https://www.benzinga.com/news/management/25/04/44663078/barrick-gold-proposes-name-change-targets-30-production-growth-by-2030">Barrick Gold Proposes Name Change, Targets 30% Production Growth By 2030</a></li>
</ul>
Photo by Skorzewiak via Shutterstock

$BTC

$ETH

US Futures Plunge On Tariff Fallout, Stir 'Great Depression-Style' Fears; Bitcoin, Ethereum, XRP, And Dogecoin Nosedive, Wiping Out $1.42 Billion In Liquidations; Tesla's Cybertruck Faces Brutal Backlash—Experts Call It Costly Misstep – Top Headlines While the U.S. Slept

Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency (AATD) at the 2025 Alpha-1 Foundation 7th Global Research Conference and <a target="_blank" href="https://www.benzinga.com/general/biotech" rel="noreferrer noopener">10th Patient Congress</a>.
AATD is an inherited genetic disorder that can cause early onset emphysema and liver disease.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44218611/gene-edit-biotech-beam-therapeutics-touts-encouraging-data-from-early-stage-gene-therapy-study-in-genetic-disorder-raises-500-million-via-equity" rel="noreferrer noopener">Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity</a>
Initial safety and efficacy data from the Phase 1/2 trial of BEAM-302 were previously&nbsp;<a target="_blank" href="https://www.globenewswire.com/Tracker?data=DGjvxT5xtICCkQ8gwO3vYKCxk4cQeGEVsiyMQrfGuDK85hfJvOf0_YRSCN3D4S2uPdzWIKOzfsxza85TGOOOmoIkpgc1qwWR9HDfBTbthTKhQDPwQrYggdlqLEDXs4WjgwVKQ_WJgjueP5aZJLXesgIntByaC3vCddeZGNP6hOg60nlrLmP-9YVZC3BBCaMhoF_Q_HvldXOxFXwKhnaNyTK85Sj9OFVYNjcCdMA9MHs=&amp;tblci=GiCUX7wvU_AgmIIiQduNYr6JQuJQLy6SZJGvpyeZuCzyqiCN1VcoxvTN4f7-y-PqATDviEo" rel="noreferrer noopener">reported</a> in March 2025, establishing clinical proof of concept as a potential treatment for AATD and&nbsp;in vivo base editing.
Preliminary results from the first three single-ascending dose cohorts demonstrated that BEAM-302 was well tolerated.
Single doses of BEAM-302 led to durable dose-dependent correction of the disease-causing mutation and total AAT protein levels above the therapeutic threshold in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44656185/beam-therapeutics-presents-additional-data-for-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-" rel="noreferrer noopener">60 mg dose cohort</a>.
These previously reported data were included in the presentation, alongside updated biomarker data from the 60 mg cohort showing levels of corrected protein (M-AAT) and the mutant form of alpha-1 antitrypsin protein (Z-AAT) out to Day 28 for all three patients.
At Day 28, the proportion of corrected M-AAT reached a mean of 91% of total AAT in circulation, surpassing levels observed in patients with the MZ genotype where circulating M-AAT is typically ~80%.
In addition, treatment with BEAM-302 led to a mean decrease of 79% of circulating mutant Z-AAT from baseline as of Day 28.
Beam plans to continue the dose-escalation portion of Part A of the ongoing Phase 1/2 trial, including enrolling and dosing a fourth dose cohort of 75 mg, and expects to report further data at a medical conference in the second half of 2025.
In addition, the company plans to dose the first patient in Part B, including AATD patients with mild to moderate liver disease, in the second half of 2025.
The U.S. Food and Drug Administration recently cleared Beam Therapeutics&#8217; investigational drug application for BEAM-302, enabling the company to activate sites in the U.S. for its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44523407/beam-therapeutics-announces-clearance-of-investigational-new-drug-application-for-beam-302-for-the" rel="noreferrer noopener">ongoing Phase 1/2 trial</a>.
Price Action: BEAM stock is down 6.75% at $14.24 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44652222/trumps-tariffs-may-shift-us-spending-from-goods-to-services-creating-uncertainty-for-ecommerce-and-advertising-industries-analyst-warns" target="_blank" rel="noreferrer noopener">Tariffs To Impact End Demand: Goldman Sachs Analyst Expects Drag On Corporate Spending, Hiring</a></li>
</ul>

Biotech

Health Care

Movers

General

BEAM

Beam Therapeutics Presents Biomarker Data For BEAM-302 Gene Therapy For Inherited Disease

Shares of The Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) are lower Monday. This comes after they traded at an <a href="https://www.benzinga.com/insights/news/25/04/44607646/1000-invested-in-this-stock-20-years-ago-would-be-worth-this-much-today">all-time high Friday</a>.
‘There's always a bull market somewhere' is an old Wall Street expression. Kroger proves that it&#8217;s true. Because of this, our team of technical analysts has made it our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
Most of the market is in a freefall.  But some of the money coming out of most stocks has been going into some others. Kroger has been one of them.
Many institutional investment managers, such as hedge funds or mutual funds, have mandates regarding how much cash they can hold. If their selling pushes the cash above the mandated level, they must buy other stocks to bring the cash level back down.
But now it looks like Kroger may be about to head lower. The stock staged a classic ‘reversal day' on Friday.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/04/44666244/how-to-trade-the-market-as-global-trade-tensions-escalate">How To Trade The Market As Global Trade Tensions Escalate</a>
When the leadership of a market is changing from the bulls to the bears, the price action can cause what technical analysts call ‘reversal patterns' to appear on a chart below. A ‘Reversal Day' is one of them.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="524" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/07100123/one5-1024x524.png" alt="" class="wp-image-860063" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/07100123/one5-1024x524.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/07100123/one5-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/07100123/one5-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/07100123/one5-1536x786.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/07100123/one5.png 1621w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Sometimes, the change of leadership takes place over an extended period of time. This can make reversal patterns like a ‘Head and Shoulders' or a ‘Rounded Top' form on the chart.
Sometimes, the change can take place in one day. The price action can form a reversal day pattern.
On Friday, it looked like Kroger&#8217;s recent rally would continue. In the morning, it traded at an all-time high of $71.93. But by the close, the bears overpowered the bulls and lowered the price to around $67.
If the bears have taken over and a downtrend forms, there is a good chance it may end around $62.25. This level was support in March.
Many of the traders and investors who sold shares while Kroger was at this support vowed to buy their shares back when the stock moved higher. But they also vowed to do so only if they could buy them for the same price they were sold at.
This means if the stock drops back to around $62.25, they will place buy orders. If there are enough of them, it will create support at the level again.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44665493/us-recession-countdown-has-begun-as-trump-tariffs-push-odds-to-45-goldman-sachs-warns">US Recession &#8216;Countdown&#8217; Has Begun As Trump Tariffs Push Odds To 45%, Goldman Sachs Warns</a></li>
</ul>
Image: Shutterstock

Technicals

Stock Of The Day: Is The Kroger Rally Finally Over?

The iShares China Large-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NASDAQ">FXI</a>), which tracks 50 of China's largest companies listed in Hong Kong, is trading lower by 4.6% to $31.22 during Monday&#8217;s session after President Donald Trump last week declared a <a href="https://www.benzinga.com/markets/25/04/44621408/market-access-has-a-price-trump-unveils-list-of-tariffs-countries-targeted">national emergency</a> to impose sweeping tariffs under the International Emergency Economic Powers Act.
In response, China on Friday hit back with a <a href="https://www.benzinga.com/news/25/04/44645172/china-retaliates-with-34-tariff-on-all-us-imports-urges-trump-to-immediately-cancel-the-tariffs-calls-for-negotiation">34% tariff</a> on all U.S. imports and export controls on rare earth minerals, further intensifying the economic clash between the world's two largest economies.
FXI, whose holdings include major players like Alibaba Group Holding Ltd &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) and JD.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), was hit particularly hard as investors priced in expectations of slowed growth, supply chain disruptions and retaliatory headwinds for Chinese exports.
Trump's emergency declaration also introduced a blanket 10% import tariff on all goods entering the U.S., with additional reciprocal tariffs targeting trade partners with large surpluses—China being the largest at $270 billion. 
<a href="https://www.benzinga.com/25/04/44665493/us-recession-countdown-has-begun-as-trump-tariffs-push-odds-to-45-goldman-sachs-warns">Analysts warn</a> that such aggressive moves could spark a global recession, and JPMorgan now sees a <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645681/jpmorgan-raises-recession-risk-to-60-as-largest-us-tax-hike-in-60-years-hits-global-economy">60% probability</a> of one hitting this year. With China <a href="https://www.benzinga.com/markets/25/04/44621408/market-access-has-a-price-trump-unveils-list-of-tariffs-countries-targeted">labeled</a> a target for "unfair trade practices," FXI is bearing the brunt of market fears that Beijing's tech and manufacturing champions could suffer amid reduced global demand and deteriorating diplomatic ties.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44662164/us-stock-futures-slump-following-massive-tariff-induced-selloff-experts-warn-of-a-brewing-great-depression-like-pattern" target="_blank" rel="noreferrer noopener">US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing ‘Great Depression-Like' Pattern</a></li>
</ul>

BABA

Why iShares China Large-Cap ETF (FXI) Is Getting Hammered

Jefferies analyst Brent Thill maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Buy and lowers the price target from $65 to $60.

Jefferies Maintains Buy on Dynatrace, Lowers Price Target to $60

Deep-pocketed investors have adopted a bullish approach towards Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COST usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 58 extraordinary options activities for Costco Wholesale. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 24% bearish. Among these notable options, 47 are puts, totaling $4,505,316, and 11 are calls, amounting to $623,489.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $600.0 and $985.0 for Costco Wholesale, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Costco Wholesale's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Costco Wholesale's significant trades, within a strike price range of $600.0 to $985.0, over the past month.
<h3>Costco Wholesale Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744034537_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$103.15</td>
<td>$101.7</td>
<td>$101.7</td>
<td>$900.00</td>
<td>$1.0M</td>
<td>1.4K</td>
<td align="right">155</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$67.0</td>
<td>$66.0</td>
<td>$66.0</td>
<td>$880.00</td>
<td>$330.0K</td>
<td>800</td>
<td align="right">82</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$63.85</td>
<td>$62.5</td>
<td>$62.5</td>
<td>$825.00</td>
<td>$212.5K</td>
<td>165</td>
<td align="right">0</td>
</tr>
<tr>
<td>COST</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$58.85</td>
<td>$56.75</td>
<td>$57.83</td>
<td>$900.00</td>
<td>$173.4K</td>
<td>338</td>
<td align="right">51</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/02/25</td>
<td>$85.35</td>
<td>$81.85</td>
<td>$83.6</td>
<td>$950.00</td>
<td>$167.2K</td>
<td>2.2K</td>
<td align="right">810</td>
</tr>
</tbody>
</table>

<h3>About Costco Wholesale</h3>
Costco operates a membership-based, no-frills retail model predicated on offering a select product assortment in bulk quantities at bargain prices. The firm avoids maintaining costly product displays by keeping inventory on pallets and limits distribution expenses by storing its inventory at point of sale in the warehouse. Given its frugal cost structure, the firm is able to price its merchandise below that of competing retailers, driving high sales volume per warehouse and generating strong profits on thin margins. Costco operates over 600 warehouses in the United States and has over 60% share in the domestic warehouse club industry. Internationally, Costco operates another 280 warehouses, primarily in Canada, Mexico, Japan, and the UK.
Following our analysis of the options activities associated with Costco Wholesale, we pivot to a closer look at the company's own performance.
<h3>Costco Wholesale's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 735,773, the COST's price is down by -4.15%, now at $878.45. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 52 days.</li>
</ul>
<h3>Professional Analyst Ratings for Costco Wholesale</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $1046.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Costco Wholesale, which currently sits at a price target of $1035. 
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Costco Wholesale, which currently sits at a price target of $980. 
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on Costco Wholesale, maintaining a target price of $1100. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Costco Wholesale, targeting a price of $1070. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Costco Wholesale options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

COST

Check Out What Whales Are Doing With COST

Bets on an emergency Federal Reserve rate cut are rising sharply Monday, as mounting fears of a looming U.S. recession and sudden, severe stock market crashes &#8211; already erasing trillions in market value &#8211; prompt speculators to anticipate swift central bank action <a href="https://www.benzinga.com/topic/federal-reserve">ahead of scheduled meetings.</a>
On the CFTC-regulated prediction market platform Kalshi, contracts betting on "the number of emergency rate cuts this year" have gained notable traction in recent hours.
Odds eyeing two emergency cuts equivalent to 50 basis points in rate easing have spiked to 10% from nearly null chances a week ago. The last time the Fed executed an emergency cut was in March 2020, when it slashed rates by 50 basis points amid the escalating COVID-19 crisis.
A $10 bet on two emergency rate cuts—equivalent to a half-point drop in interest rates—would return $90 if realized. 
Meanwhile, Fed futures are now pricing in five rate cuts by the end of the year, according to the CME FedWatch tool.
Traders are growing wary of cracks in the U.S. economy. The sudden rise in rate cut wagers reflects a broader fear: that either markets or the macroeconomic picture could deteriorate so quickly that the Fed is forced to step in ahead of schedule.
<iframe loading="lazy" src="https://kalshi.com/external-widgets/events/KXEMERCUTS-25?color_scheme=light&#038;widget_size=medium&#038;variant=a&#038;ids=KXEMERCUTS-25-T0&#038;ids=KXEMERCUTS-25-T2&#038;ids=KXEMERCUTS-25-T1&#038;utm_campaign=benzinga_widget" width="488px" height="196px" style="border:0"></iframe>
<h3 class="wp-block-heading">Conspiracy Theories of A Self-Engineered Recession Emerge</h3>
Fueling the speculative fire are political theories that the Trump administration may be intentionally inducing a recession. 
The logic? Lower inflation, lower interest rates and stronger control over monetary conditions.
On Monday, Trump took to Truth Social with a bold message: "Oil prices are down, interest rates are down (the slow moving Fed should cut rates!), food prices are down, there is NO INFLATION." He also emphasized the revenue generated from tariffs, claiming the U.S. is "bringing in Billions of Dollars a week from the abusing countries."
Last Friday, Trump openly urged Fed Chair Jerome Powell to act swiftly. "This would be a PERFECT time for Fed Chairman Jerome Powell to cut Interest Rates. He is always &#8216;late,&#8217; but he could now change his image, and quickly."
Peter Navarro, former trade adviser, downplayed the recession fears entirely, stating, "Any discussion of recession seems silly at this moment."
Larry Tentarelli, chief technical strategist at Blue Chip Daily Trend Report, now sees a 50% base-case probability for a 2025 recession — especially if the "tariff news cycle remains unchanged." 
Tentarelli warns that the absence of a so-called "Fed put" — the idea that the Fed will always step in to stabilize markets — leaves the economy more exposed than usual.
Goldman Sachs has revised its recession odds up to 45%, while JPMorgan has gone even higher, projecting a 60% chance.
<h3 class="wp-block-heading">Yardeni Pushes Back On Political Manipulation Narrative</h3>
Not all agree with the conspiracy framing. Market veteran Ed Yardeni dismissed the theory that Trump is engineering a downturn to drive rates lower. 
Still, he outlined how the idea has gained traction. First, a recession could weaken the dollar, stimulate exports and shrink the U.S. trade deficit.
Subsequently, Trump's tariffs could push manufacturers back to U.S. soil while reducing the foreign demand for American agricultural products.
In the end, lower inflation from these forces could justify a looser Fed policy and potentially lower mortgage rates.
Still, Yardeni warned that even if these theories are unfounded, the consequences of poor economic management are real and potentially devastating.
&#8220;We believe that Wall Street and Main Street prosper and suffer together. The Trump administration disagrees,&#8221; he said in a note Monday.
The S&amp;P 500 index—as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)—has lost 13% since Trump&#8217;s tariff announcement last Wednesday, notching one of the deepest and fastest selloffs in modern history.
<h3 class="wp-block-heading">Stock Market Exposure Raises Stakes For American Households</h3>
The stock market's vulnerability is perhaps the most immediate concern. According to Gallup's latest poll, 62% of U.S. adults hold some form of stock market investment. 
That figure jumps to 87% among upper-income Americans earning more than $100,000 a year, while 65% of middle-income earners also have market exposure. Among lower-income households earning below $40,000, the rate falls to 25%.
Data from the Federal Reserve shows that U.S. households and nonprofit organizations now hold a record 43.5% of their financial assets in equities. This heavy concentration means that a sharp drop in stock prices could have outsized effects on consumer spending and confidence. 
At the end of 2024, American households held $46.8 trillion in corporate equities and mutual funds. Of that, Baby Boomers alone controlled $25.2 trillion. A 20% decline in equity prices would wipe out $9.4 trillion in household wealth — including $5 trillion from Baby Boomer portfolios, many of which are meant to fund retirements.
This sets up a dangerous dynamic: if equity markets keep falling, the resulting negative wealth effect could lead to a deep contraction in consumption, hitting middle- and lower-income households the hardest.
The confluence of economic signals, political pressure and financial market stress is pushing the Federal Reserve closer to a moment of reckoning. 
Whether the recession is engineered or not, the damage is mounting. 
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44662991/goldman-sachs-raises-risk-of-recession-to-45-jefferies-calls-tariffs-a-free-hall-pass-for-tech-giants-to-reset-their-goals">Goldman Sachs Raises Risk Of Recession to 45%: Jefferies Calls Tariffs a &#8216;Free Hall Pass&#8217; For Tech Giants To Reset Their Goals</a></li>
</ul>
Photo: Shutterstock

Equities

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

Speculators Raise Wagers On Fed Emergency Rate Cuts As Theories Of Self-Induced Crash Gather Pace

Whales with a lot of money to spend have taken a noticeably bullish stance on GE Vernova.
Looking at options history for GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $246,150 and 11, calls, for a total amount of $560,184.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $260.0 and $380.0 for GE Vernova, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for GE Vernova's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of GE Vernova's whale trades within a strike price range from $260.0 to $380.0 in the last 30 days. 
<h3>GE Vernova Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744034532_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$28.6</td>
<td>$28.0</td>
<td>$28.0</td>
<td>$300.00</td>
<td>$179.2K</td>
<td align="right">193</td>
<td align="right">0</td>
</tr>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/20/26</td>
<td>$91.4</td>
<td>$88.0</td>
<td>$91.4</td>
<td>$310.00</td>
<td>$91.4K</td>
<td align="right">339</td>
<td align="right">10</td>
</tr>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$110.0</td>
<td>$108.0</td>
<td>$108.0</td>
<td>$380.00</td>
<td>$75.6K</td>
<td align="right">93</td>
<td align="right">7</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$29.1</td>
<td>$28.0</td>
<td>$29.0</td>
<td>$300.00</td>
<td>$72.5K</td>
<td align="right">193</td>
<td align="right">89</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$29.2</td>
<td>$29.2</td>
<td>$29.2</td>
<td>$300.00</td>
<td>$55.4K</td>
<td align="right">193</td>
<td align="right">108</td>
</tr>
</tbody>
</table>

<h3>About GE Vernova</h3>
GE Vernova is a global leader in the electric power industry, with products and services that generate, transfer, convert, and store electricity. The company has three business segments: power, wind, and electrification. Power includes gas, nuclear, hydroelectric, and steam technologies, providing dispatchable power. The wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. Electrification includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, and storage of electricity from the point of generation to point of consumption.
After a thorough review of the options trading surrounding GE Vernova, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>GE Vernova's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 392,871, the GEV's price is down by -5.55%, now at $256.41. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 16 days.</li>
</ul>
<h3>What Analysts Are Saying About GE Vernova</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $409.33.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Susquehanna downgraded its rating to Positive, setting a price target of $370. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on GE Vernova with a target price of $445. 
&#x2A; An analyst from Jefferies has decided to maintain their Buy rating on GE Vernova, which currently sits at a price target of $413. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for GE Vernova with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

A Closer Look at GE Vernova's Options Market Dynamics

Financial giants have made a conspicuous bearish move on ServiceNow. Our analysis of options history for ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) revealed 25 unusual trades.
Delving into the details, we found 36% of traders were bullish, while 52% showed bearish tendencies. Out of all the trades we spotted, 20 were puts, with a value of $771,984, and 5 were calls, valued at $353,470.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $400.0 to $1220.0 for ServiceNow over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for ServiceNow options trades today is 110.48 with a total volume of 236.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for ServiceNow's big money trades within a strike price range of $400.0 to $1220.0 over the last 30 days.
<h3>ServiceNow Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744034527_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$112.1</td>
<td>$112.0</td>
<td>$112.0</td>
<td>$720.00</td>
<td>$224.0K</td>
<td align="right">25</td>
<td align="right">20</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$32.4</td>
<td>$30.8</td>
<td>$32.4</td>
<td>$600.00</td>
<td>$90.7K</td>
<td align="right">304</td>
<td align="right">1</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$11.6</td>
<td>$11.0</td>
<td>$11.4</td>
<td>$420.00</td>
<td>$57.0K</td>
<td align="right">0</td>
<td align="right">186</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$531.4</td>
<td>$522.3</td>
<td>$531.4</td>
<td>$1220.00</td>
<td>$53.1K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$165.2</td>
<td>$157.2</td>
<td>$161.8</td>
<td>$850.00</td>
<td>$48.5K</td>
<td align="right">216</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About ServiceNow</h3>
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
Having examined the options trading patterns of ServiceNow, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of ServiceNow</h3>
<ul>
<li>With a volume of 252,212, the price of NOW is down -5.78% at $679.97. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 16 days.</li>
</ul>
<h3>What Analysts Are Saying About ServiceNow</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1072.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on ServiceNow, which currently sits at a price target of $950. 
&#x2A; An analyst from UBS persists with their Buy rating on ServiceNow, maintaining a target price of $1000. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for ServiceNow, targeting a price of $1100. 
&#x2A; An analyst from Baird persists with their Outperform rating on ServiceNow, maintaining a target price of $1010. 
&#x2A; Reflecting concerns, an analyst from Citizens Capital Markets lowers its rating to Market Outperform with a new price target of $1300.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for ServiceNow with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

ServiceNow Options Trading: A Deep Dive into Market Sentiment

Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-08. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Aehr Test Systems to report an earnings per share (EPS) of $0.04.
Anticipation surrounds Aehr Test Systems's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $0.02, leading to a 27.08% drop in the share price the following trading session.
Here's a look at Aehr Test Systems's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.04</td>
<td>0.02</td>
<td>0.10</td>
<td>-0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.02</td>
<td>0.07</td>
<td>0.84</td>
<td>-0.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-27.0%</td>
<td>20.0%</td>
<td>22.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744034526_0.png" alt="eps graph" />
<h3>Tracking Aehr Test Systems's Stock Performance</h3>
Shares of Aehr Test Systems were trading at $7.26 as of April 04. Over the last 52-week period, shares are down 42.87%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/AEHR/earnings">To track all earnings releases for Aehr Test Systems visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AEHR

Earnings Preview: Aehr Test Systems

Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $49.5, a high estimate of $64.00, and a low estimate of $35.00. Experiencing a 4.81% decline, the current average is now lower than the previous average price target of $52.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744034515_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of General Motors among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Daniel Roeska &#x7C;Bernstein &#x7C;Lowers &#x7C;Underperform &#x7C; $35.00&#x7C;$50.00 &#x7C; 
&#x7C;Ryan Brinkman &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $53.00&#x7C;$64.00 &#x7C; 
&#x7C;Alexander Potter &#x7C;Piper Sandler &#x7C;Raises &#x7C;Neutral &#x7C; $48.00&#x7C;$45.00 &#x7C; 
&#x7C;Colin Langan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Underweight &#x7C; $37.00&#x7C;$35.00 &#x7C; 
&#x7C;Edison Yu &#x7C;Deutsche Bank &#x7C;Raises &#x7C;Buy &#x7C; $60.00&#x7C;$56.00 &#x7C; 
&#x7C;Patrick Hummel &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $64.00&#x7C;$62.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to General Motors. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of General Motors compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for General Motors's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into General Motors's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on General Motors analyst ratings.</a>
<h2>Discovering General Motors: A Closer Look</h2>
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2024's share was 17.0%. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.
<h3>General Motors's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: General Motors displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 10.99%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: General Motors's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -3.62%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): General Motors's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -2.57%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): General Motors's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.61% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: General Motors's debt-to-equity ratio surpasses industry norms, standing at 2.07. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

6 Analysts Assess General Motors: What You Need To Know

Mama`s Creations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMA#NASDAQ">MAMA</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-08. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Mama`s Creations will report an earnings per share (EPS) of $0.03.
Investors in Mama`s Creations are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS missed by $0.03, leading to a 14.95% drop in the share price on the subsequent day.
Here's a look at Mama`s Creations's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.04</td>
<td>0.02</td>
<td>0.02</td>
<td>0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.01</td>
<td>0.03</td>
<td>0.01</td>
<td>0.04</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-15.0%</td>
<td>-0.0%</td>
<td>-5.0%</td>
<td>9.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744034515_0_0.png" alt="eps graph" />
<h3>Tracking Mama`s Creations's Stock Performance</h3>
Shares of Mama`s Creations were trading at $6.81 as of April 04. Over the last 52-week period, shares are up 43.75%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MAMA/earnings">To track all earnings releases for Mama`s Creations visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MAMA

A Look Ahead: Mama's Creations's Earnings Forecast

6 analysts have expressed a variety of opinions on Portillos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLO#NASDAQ">PTLO</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $14.17, with a high estimate of $17.00 and a low estimate of $12.00. Staying constant with the previous average price target, the current average remains unchanged. 
<img src="https://www.benzinga.com/files/images/story/2025/1744034503_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Portillos's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;David Tarantino &#x7C;Baird &#x7C;Lowers &#x7C;Neutral &#x7C; $12.00&#x7C;$15.00 &#x7C; 
&#x7C;Chris O'Cull &#x7C;Stifel &#x7C;Raises &#x7C;Buy &#x7C; $17.00&#x7C;$16.00 &#x7C; 
&#x7C;Jim Salera &#x7C;Stephens &amp; Co. &#x7C;Raises &#x7C;Equal-Weight &#x7C; $14.00&#x7C;$13.00 &#x7C; 
&#x7C;Jim Salera &#x7C;Stephens &amp; Co. &#x7C;Maintains &#x7C;Equal-Weight &#x7C; $13.00&#x7C;$13.00 &#x7C; 
&#x7C;Chris O'Cull &#x7C;Stifel &#x7C;Raises &#x7C;Buy &#x7C; $16.00&#x7C;$13.00 &#x7C; 
&#x7C;Brian Harbour &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $13.00&#x7C;$15.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Portillos. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Portillos compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Portillos's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Portillos's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PTLO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Portillos analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Portillos's Background</h2>
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
<h3>Financial Milestones: Portillos's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Portillos faced challenges, resulting in a decline of approximately -1.73% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Portillos's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 6.1%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.88%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Portillos's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.76%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.49, Portillos adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PTLO

The Analyst Verdict: Portillos In The Eyes Of 6 Experts

Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) will release its quarterly earnings report on Tuesday, 2025-04-08. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Tilray Brands to report an earnings per share (EPS) of $-0.03.
Tilray Brands bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.01 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at Tilray Brands's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.01</td>
<td>-0.04</td>
<td>-0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>-0.01</td>
<td>0.04</td>
<td>0</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-10.0%</td>
<td>3.0%</td>
<td>10.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744034502_0.png" alt="eps graph" />
<h3>Market Performance of Tilray Brands's Stock</h3>
Shares of Tilray Brands were trading at $0.5922 as of April 04. Over the last 52-week period, shares are down 73.12%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/TLRY/earnings">To track all earnings releases for Tilray Brands visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TLRY

Tilray Brands Earnings Preview

Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">9</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Celanese and provided 12-month price targets. The average target is $64.33, accompanied by a high estimate of $88.00 and a low estimate of $46.00. This current average has decreased by 20.3% from the previous average price target of $80.72. 
<img src="https://www.benzinga.com/files/images/story/2025/1744034488_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Charles Neivert &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Underweight &#x7C; $48.00&#x7C;$50.00 &#x7C; 
&#x7C;Patrick Cunningham &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $52.00&#x7C;$58.00 &#x7C; 
&#x7C;David Begleiter &#x7C;Deutsche Bank &#x7C;Raises &#x7C;Buy &#x7C; $75.00&#x7C;$70.00 &#x7C; 
&#x7C;Stephen Richardson &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;In-Line &#x7C; $75.00&#x7C;$85.00 &#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Maintains &#x7C;Overweight &#x7C; $76.00&#x7C;$76.00 &#x7C; 
&#x7C;Charles Neivert &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Underweight &#x7C; $50.00&#x7C;$77.00 &#x7C; 
&#x7C;Michael Leithead &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $59.00&#x7C;$75.00 &#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Buy &#x7C; $72.00&#x7C;$88.00 &#x7C; 
&#x7C;Arun Viswanathan &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $56.00&#x7C;$84.00 &#x7C; 
&#x7C;David Begleiter &#x7C;Deutsche Bank &#x7C;Lowers &#x7C;Buy &#x7C; $70.00&#x7C;$85.00 &#x7C; 
&#x7C;Jeffrey Zekauskas &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $54.00&#x7C;$92.00 &#x7C; 
&#x7C;Joshua Spector &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $60.00&#x7C;$72.00 &#x7C; 
&#x7C;John McNulty &#x7C;BMO Capital &#x7C;Lowers &#x7C;Underperform &#x7C; $46.00&#x7C;$73.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $55.00&#x7C;$75.00 &#x7C; 
&#x7C;Ghansham Panjabi &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $67.00&#x7C;$110.00 &#x7C; 
&#x7C;Michael Leithead &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $75.00&#x7C;$88.00 &#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Buy &#x7C; $88.00&#x7C;$95.00 &#x7C; 
&#x7C;Vincent Andrews &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $80.00&#x7C;$100.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Celanese. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Celanese analyst ratings.</a>
<h2>Get to Know Celanese Better</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>A Deep Dive into Celanese's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Celanese faced challenges, resulting in a decline of approximately -7.75% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -80.76%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Celanese's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -30.75%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Celanese's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -7.85%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Celanese's debt-to-equity ratio stands notably higher than the industry average, reaching 2.5. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Celanese Stock: Analyst Perspectives (18 Ratings)

USA CB Employment Trends Index For March 109.03 Vs 108.47 Prior

Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) will release its quarterly earnings report on Tuesday, 2025-04-08. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Kura Sushi USA to report an earnings per share (EPS) of $-0.10.
Kura Sushi USA bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings History Snapshot</h3>
Last quarter the company beat EPS by $0.12, which was followed by a 11.83% drop in the share price the next day.
Here's a look at Kura Sushi USA's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.20</td>
<td>0</td>
<td>0.16</td>
<td>-0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.08</td>
<td>0.09</td>
<td>0</td>
<td>-0.09</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-12.0%</td>
<td>-8.0%</td>
<td>-16.0%</td>
<td>6.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744034480_0.png" alt="eps graph" />
<h3>Kura Sushi USA Share Price Analysis</h3>
Shares of Kura Sushi USA were trading at $43.61 as of April 04. Over the last 52-week period, shares are down 65.13%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Observations about Kura Sushi USA</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Kura Sushi USA.
With 7 analyst ratings, Kura Sushi USA has a consensus rating of Neutral. The average one-year price target is $85.14, indicating a potential 95.23% upside.
<h3>Comparing Ratings with Competitors</h3>
The below comparison of the analyst ratings and average 1-year price targets of and Bloomin Brands, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Bloomin Brands, with an average 1-year price target of $11.38, suggesting a potential 73.91% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for and Bloomin Brands, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kura Sushi USA</td>
<td>Neutral</td>
<td>25.22%</td>
<td>$7.37M</td>
<td>-0.49%</td>
</tr>
<tr>
<td>Bloomin Brands</td>
<td>Neutral</td>
<td>-13.52%</td>
<td>$80.47M</td>
<td>-42.08%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Kura Sushi USA ranks higher than its peers in revenue growth and gross profit, indicating stronger performance in these areas. However, it lags behind in return on equity compared to its peers. Overall, Kura Sushi USA is positioned in the middle among its peers based on the provided metrics.
<h3>Get to Know Kura Sushi USA Better</h3>
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
<h3>Kura Sushi USA: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Kura Sushi USA showcased positive performance, achieving a revenue growth rate of 25.22% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.49%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Kura Sushi USA's ROE stands out, surpassing industry averages. With an impressive ROE of -0.49%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Kura Sushi USA's ROA excels beyond industry benchmarks, reaching -0.26%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.67, Kura Sushi USA adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/KRUS/earnings">To track all earnings releases for Kura Sushi USA visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KRUS

A Glimpse of Kura Sushi USA's Earnings Potential

Medtronic's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) short percent of float has fallen 4.76% since its last report. The company recently reported that it has 12.83 million shares sold short, which is 1.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Medtronic Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744034457_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medtronic has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Medtronic's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Medtronic's peer group average for short interest as a percentage of float is 4.55%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Medtronic's Recent Short Interest

Vulcan Materials's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) short percent of float has risen 13.42% since its last report. The company recently reported that it has 1.97 million shares sold short, which is 1.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.04 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Vulcan Materials Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744034452_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Vulcan Materials has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Vulcan Materials's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Vulcan Materials's peer group average for short interest as a percentage of float is 3.06%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Vulcan Materials?

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE

Legal

FORTREA ALERT: Bragar Eagel & Squire, P.C. is Investigating Fortrea Holdings Inc. on Behalf of Fortrea Stockholders and Encourages Investors to Contact the Firm

Small Cap

Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Bragar Eagel & Squire, P.C. Is Investigating Fortrea and Ibotta and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Fortrea Holdings Inc. - FTRE

IBTA

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Cytek Biosciences

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Fortrea Holdings

Fortrea Holdings (FTRE) Opciones

Fortrea Holdings (NASDAQ:FTRE) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL